Pericardial effusion is a medical condition characterized by the abnormal buildup of fluid within the pericardial sac, a protective membrane enveloping the heart. This accumulation can arise from a diverse range of factors, including infectious agents, inflammatory disorders, traumatic injuries, or pre-existing health conditions. The presence of excess fluid in the pericardial sac exerts pressure on the heart, potentially impairing its normal functioning. Individuals with pericardial effusion may experience a spectrum of symptoms, with chest pain, shortness of breath, and fatigue being commonly reported. These symptoms can significantly impact a person's quality of life and may necessitate prompt medical attention. Diagnosis typically involves specialized imaging techniques such as echocardiography, enabling healthcare professionals to visualize the extent of fluid accumulation and assess its impact on cardiac function. The underlying cause of pericardial effusion guides the course of treatment. Management strategies may include addressing the root cause, such as treating infections or managing inflammatory conditions. In certain instances, medical interventions like drainage procedures or the administration of anti-inflammatory medications may be recommended to alleviate symptoms and prevent potential complications.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States